368 related articles for article (PubMed ID: 33740526)
1. Effect and mechanism of berberine against polycystic ovary syndrome.
Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L
Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526
[TBL] [Abstract][Full Text] [Related]
2. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
Wei W; Zhao H; Wang A; Sui M; Liang K; Deng H; Ma Y; Zhang Y; Zhang H; Guan Y
Eur J Endocrinol; 2012 Jan; 166(1):99-105. PubMed ID: 22019891
[TBL] [Abstract][Full Text] [Related]
3. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
Shen HR; Xu X; Li XL
Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
[TBL] [Abstract][Full Text] [Related]
4. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
Kuang H; Duan Y; Li D; Xu Y; Ai W; Li W; Wang Y; Liu S; Li M; Liu X; Shao M
PLoS One; 2020; 15(8):e0235404. PubMed ID: 32785222
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review.
Li MF; Zhou XM; Li XL
Evid Based Complement Alternat Med; 2018; 2018():2532935. PubMed ID: 30538756
[TBL] [Abstract][Full Text] [Related]
7. Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression.
He S; Li H; Zhang Q; Zhao W; Li W; Dai C; Li B; Cheng J; Wu S; Zhou Z; Yang J; Li S
Phytomedicine; 2024 Jun; 128():155456. PubMed ID: 38537446
[TBL] [Abstract][Full Text] [Related]
8. The role of berberine in polycystic ovary syndrome - a summary of knowledge.
Jurgiel J; Graniak A; Opyd P; Zawodny T; Lis M
Ginekol Pol; 2024; 95(4):276-284. PubMed ID: 38108460
[TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
10. New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties.
Xia Q; Wang W; Liu Z; Xiao J; Qiao C; Zhao Y; Li B; Liu Y; Peng Y; Yang X; Shi J; Gao X; Wang D
Eur J Pharmacol; 2023 Jan; 939():175433. PubMed ID: 36535493
[TBL] [Abstract][Full Text] [Related]
11. Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study.
Rondanelli M; Riva A; Petrangolini G; Allegrini P; Giacosa A; Fazia T; Bernardinelli L; Gasparri C; Peroni G; Perna S
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684666
[TBL] [Abstract][Full Text] [Related]
12. Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance.
Li L; Xiao Y; Zhou J; Mo H; Li X; Li Y; Wang Y; Zhong M
Heliyon; 2024 Jan; 10(2):e24338. PubMed ID: 38293350
[TBL] [Abstract][Full Text] [Related]
13. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial.
Li Y; Ma H; Zhang Y; Kuang H; Ng EH; Hou L; Wu X
Trials; 2013 Jul; 14():226. PubMed ID: 23866924
[TBL] [Abstract][Full Text] [Related]
14. The effect and safety of Berberine on polycystic ovary syndrome: a systematic review.
Mirzaee F; Razmjouei P; Shahrahmani H; Vafisani F; Najaf Najafi M; Ghazanfarpour M
J Obstet Gynaecol; 2021 Jul; 41(5):684-689. PubMed ID: 32811221
[TBL] [Abstract][Full Text] [Related]
15. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
[TBL] [Abstract][Full Text] [Related]
16. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
19. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
Zhu Y; Li Y; Liu M; Hu X; Zhu H
Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
[TBL] [Abstract][Full Text] [Related]
20. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
